Drug Discovery & Pharmaceuticals

RSS

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Insilico Medicine, a biotechnology company developing an end-to-end drug discovery pipeline utilizing next-generation artificial intelligence, today announced a technology partnership with Arctoris, the world's first fully automated drug discovery platform, offering remotely accessible, pre-optimized and fully validated R&D processes for its partners and clients globally.

9 Jul 2020

Characterizing Polymorphs and Amorphous Form

Dr. Matteo Daldosso and Dr. Sebastian Wegner discuss novel solutions for the characterization of polymorphs and amorphous form APIs.

From Bruker BioSpin - NMR, EPR and Imaging 8 Jul 2020

Researchers discover novel class of safer analgesics

Researchers at LSU Health New Orleans Neuroscience Center of Excellence and colleagues have discovered a new class of pipeline drugs to relieve pain and reduce fever without the danger of addiction or damage to the liver or kidneys.

6 Jul 2020

New drug discovery shows promise in fighting acute respiratory illnesses

A collaboration between the University of Toronto's Faculty of Dentistry and the National Jewish Health in Denver -- the top-ranked respiratory research hospital in the U.S. -- has yielded a new drug discovery that could be useful to combat inflammation of all varieties and shows promise in fighting acute respiratory illnesses such as COVID-19.

2 Jul 2020

Researchers discover marine alga from Kiel Fjord as potential remedy against infections, skin cancer

Healing with the help of marine organisms is no utopia. Already 12 life-saving drugs, e.g. against cancer, have been developed from marine organisms and their symbiotic microbiota.

2 Jul 2020

New approach holds incredible potential for developing new therapeutics

Nearly every drug that is, or has ever been, used was derived from nature -- harnessing compounds created by organisms over eons to fight diseases. But decades ago, biochemists postulated that it might be possible to design a new drug from scratch by linking up amino acids in precise ways.

30 Jun 2020

Scientists design chiral ligands to generate useful compounds

Currently, various therapeutic compounds in the market, such as proteins, enzymes, and amino acids, are "chiral compounds"--molecules with two structures that are "mirror" images of each other but cannot be superimposed.

30 Jun 2020

Sanford Burnham Prebys announces research agreement with Lilly to identify COVID-19 antibodies

Sanford Burnham Prebys Medical Discovery Institute today announced a research agreement with Eli Lilly and Company (Lilly) to characterize Lilly's next-generation anti-SARS-CoV-2 antibodies.

29 Jun 2020

A novel strategy to achieve site-selective chiral drug synthesis in living systems

Enantioselectivity plays an important role in the pharmacological and toxicological processes of chiral drugs.

26 Jun 2020

Chemically engineered peptides could help fight persistent human health challenges

Chemically engineered peptides, designed and developed by a team of researchers at Rensselaer Polytechnic Institute, could prove valuable in the battle against some of the most persistent human health challenges.

26 Jun 2020

New steroid compounds from deep-water starfish show anticancer activity

Russian scientists from Far Eastern Federal University, G. B. Elyakov Pacific Institute of Bioorganic Chemistry, and A.V. Zhirmunsky National Scientific Center for Marine Biology have discovered four new steroid substances which target cells of human breast cancer, and colorectal carcinoma.

26 Jun 2020

GlobalData: Uncertainty during COVID-19 increases demand for immunity-boosting products

Ongoing research around protective immunity against COVID-19 has not yet helped to define ways of how the public can protect themselves from the illness, minimize the symptoms, and avoid re-infection.

26 Jun 2020

Academy of Finland funds projects for vaccine and drug development for COVID-19

The Academy of Finland has selected the projects to be funded from the call for research into COVID-19 vaccines and pharmaceutical development.

25 Jun 2020

Researchers investigate nelarabine drug for treating leukemia

Acute lymphoblastic leukemia (ALL) is the most common kind of cancer in children. T-ALL, a subtype that resembles T-lymphocytes, can be treated successfully with the drug nelarabine.

24 Jun 2020

New virtual incubator can catalyze early-stage drug discovery and development

Samsara BioCapital, a leading life sciences investment firm, Evotec SE, a global drug discovery alliance and development partnership company (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809), and KCK Ltd., a family investment fund, today announced the launch of Autobahn Labs, a novel virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development.

24 Jun 2020

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

The University of Kentucky announced a research collaboration with Atomwise, an industry leader in using artificial intelligence (AI) for small molecule discovery, to explore potential COVID-19 therapies

23 Jun 2020

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Syracuse University chemistry professor Dr. Robert P. Doyle has developed a new drug lead to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar without the common side effects of nausea, vomiting, and in select cases, undesired weight loss.

23 Jun 2020

Jubilant Therapeutics announces preclinical data of dual LSD1 and HDAC6 inhibitor at AACR 2020

Jubilant Therapeutics Inc., a biopharmaceutical company advancing small molecule modulators to address unmet medical needs in oncology and autoimmune diseases, today announced that preclinical data of dual LSD1 and HDAC6 inhibitor JBI-802, will be presented in a poster session at the American Association for Cancer Research 2020 Virtual Annual Meeting II.

23 Jun 2020

UQ superbug drug discoveries will be fast-tracked under international research deal

Antibiotics discovered at The University of Queensland will be fast-tracked under an US$11 million international research deal.

22 Jun 2020

UAH researchers assess treatment efficacy of naturally occurring compounds against COVID-19

The Baudry Lab at The University of Alabama in Huntsville has identified 125 naturally occurring compounds that have a computational potential for efficacy against the COVID-19 virus from the first batch of 50,000 rapidly assessed by a supercomputer.

22 Jun 2020

Drug Discovery & Pharmaceuticals

Insilico Medicine, Arctoris announce technology partnership to discover new COVID-19 drugs

Characterizing Polymorphs and Amorphous Form

Researchers discover novel class of safer analgesics

New drug discovery shows promise in fighting acute respiratory illnesses

Researchers discover marine alga from Kiel Fjord as potential remedy against infections, skin cancer

New approach holds incredible potential for developing new therapeutics

Scientists design chiral ligands to generate useful compounds

Sanford Burnham Prebys announces research agreement with Lilly to identify COVID-19 antibodies

A novel strategy to achieve site-selective chiral drug synthesis in living systems

Chemically engineered peptides could help fight persistent human health challenges

New steroid compounds from deep-water starfish show anticancer activity

GlobalData: Uncertainty during COVID-19 increases demand for immunity-boosting products

Academy of Finland funds projects for vaccine and drug development for COVID-19

Researchers investigate nelarabine drug for treating leukemia

New virtual incubator can catalyze early-stage drug discovery and development

UK announces research partnership with Atomwise to explore potential COVID-19 therapies

Chemist develops new drug to treat type 2 diabetes without undesired side effects

Jubilant Therapeutics announces preclinical data of dual LSD1 and HDAC6 inhibitor at AACR 2020

UQ superbug drug discoveries will be fast-tracked under international research deal

UAH researchers assess treatment efficacy of naturally occurring compounds against COVID-19

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest Life Science News